High impactLayoffs

Enanta Pharmaceuticals Cuts 37 Jobs in Fiscal Year-End Restructuring

NewsData.io · United States · Sep 29, 2026

Enanta Pharmaceuticals, a Watertown, Massachusetts-based antiviral and immunology biotech, has laid off 37 employees as part of a company-wide rightsizing effort at its fiscal year end. The cuts represent roughly 30% of its 120-person workforce reported as of September 2025. The company cited a need to operate more efficiently while pursuing key clinical readouts for its RSV antiviral zelicapavir and immunology candidate EDP-978. Recruiters with biotech and pharmaceutical placements may find displaced candidates with antiviral and immunology expertise entering the market.

Get the weekly brief by email

What changed in staffing last week, every Monday morning. Free. Unsubscribe anytime.

Enanta Pharmaceuticalsbiotechpharmaceuticalslife sciences

Related stories